Deferred Tax Assets, Valuation Allowance of Y-mAbs Therapeutics, Inc. from 31 Dec 2017 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: Y-mAbs Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2017 to 31 Dec 2024.
Y-mAbs Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $151,191,000, a 1.5% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Y-mAbs Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$151,191,000	+$2,231,000	+1.5%	31 Dec 2024	10-K	04 Mar 2025	2024	FY
Q4 2023	$148,960,000	+$6,406,000	+4.5%	31 Dec 2023	10-K	04 Mar 2025	2024	FY
Q4 2022	$142,554,000	+$25,117,000	+21%	31 Dec 2022	10-K	29 Feb 2024	2023	FY
Q4 2021	$117,437,000	+$20,977,000	+22%	31 Dec 2021	10-K	30 Mar 2023	2022	FY
Q4 2020	$96,460,000	+$30,971,000	+47%	31 Dec 2020	10-K	01 Mar 2022	2021	FY
Q4 2019	$65,489,000	+$33,422,000	+104%	31 Dec 2019	10-K	01 Mar 2021	2020	FY
Q4 2018	$32,067,000	+$16,380,000	+104%	31 Dec 2018	10-K	12 Mar 2020	2019	FY
Q4 2017	$15,687,000			31 Dec 2017	10-K	22 Mar 2019	2018	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.